IGM Biosciences Inc (IGMS)
7.185
-0.22
(-3.04%)
USD |
NASDAQ |
Apr 19, 16:00
7.185
0.00 (0.00%)
After-Hours: 20:00
IGM Biosciences Price: 7.185 for April 19, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 18, 2024 | 8.01 | 8.266 | 7.12 | 7.41 | 446866.0 |
Apr 17, 2024 | 9.37 | 9.37 | 8.050 | 8.13 | 252208.0 |
Apr 16, 2024 | 9.18 | 9.56 | 8.99 | 9.20 | 140343.0 |
Apr 15, 2024 | 9.14 | 9.79 | 8.93 | 9.41 | 185549.0 |
Apr 12, 2024 | 8.32 | 9.30 | 8.283 | 9.16 | 321381.0 |
Apr 11, 2024 | 8.27 | 8.41 | 8.09 | 8.36 | 232692.0 |
Apr 10, 2024 | 8.74 | 8.74 | 7.93 | 8.18 | 238041.0 |
Apr 09, 2024 | 8.81 | 9.07 | 8.64 | 8.74 | 170556.0 |
Apr 08, 2024 | 8.86 | 9.14 | 8.605 | 8.76 | 125594.0 |
Apr 05, 2024 | 8.75 | 9.11 | 8.59 | 8.76 | 98674.00 |
Apr 04, 2024 | 9.21 | 9.52 | 8.86 | 8.89 | 126699.0 |
Apr 03, 2024 | 9.33 | 9.33 | 8.66 | 9.03 | 138812.0 |
Apr 02, 2024 | 9.27 | 9.36 | 8.95 | 9.14 | 142102.0 |
Apr 01, 2024 | 10.47 | 10.85 | 9.31 | 9.45 | 270688.0 |
Mar 28, 2024 | 9.28 | 9.71 | 9.201 | 9.65 | 244280.0 |
Mar 27, 2024 | 8.79 | 9.41 | 8.65 | 9.27 | 264843.0 |
Mar 26, 2024 | 8.78 | 9.092 | 8.21 | 8.68 | 592532.0 |
Mar 25, 2024 | 10.35 | 10.57 | 8.625 | 8.71 | 334231.0 |
Mar 22, 2024 | 10.28 | 10.58 | 10.14 | 10.29 | 137058.0 |
Mar 21, 2024 | 9.82 | 10.27 | 9.64 | 10.23 | 155130.0 |
Mar 20, 2024 | 9.92 | 10.20 | 9.675 | 9.86 | 248280.0 |
Mar 19, 2024 | 10.25 | 10.43 | 9.85 | 9.92 | 131209.0 |
Mar 18, 2024 | 10.49 | 10.92 | 10.30 | 10.44 | 173737.0 |
Mar 15, 2024 | 10.06 | 10.69 | 10.02 | 10.64 | 360526.0 |
Mar 14, 2024 | 9.82 | 10.43 | 9.67 | 10.20 | 317206.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.94
Minimum
Oct 31 2023
121.23
Maximum
Feb 09 2021
37.61
Average
23.16
Median
Feb 01 2023
Price Benchmarks
Inotiv Inc | 4.33 |
Synlogic Inc | 1.88 |
BioXcel Therapeutics Inc | 2.77 |
Xilio Therapeutics Inc | 1.17 |
NovaBay Pharmaceuticals Inc | 0.0811 |
Price Related Metrics
PS Ratio | 176.32 |
Price to Book Value | 2.078 |
Earnings Yield | -66.53% |
Market Cap | 422.38M |